✦ LIBER ✦

P1073 PEGINTERFERON-INDUCED HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE AND SEROREVERSION IN CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON: A LONG-TERM FOLLOW-UP STUDY

✍ Scribed by Luo, K.; Liu, Z.; He, H.; Yang, G.

Book ID: 122194225
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 78 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61233-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Seroclearance rate of hepatitis B surfac

Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up

✍ Mariko Kobayashi, Tetsuya Hosaka, Fumitaka Suzuki… 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 394 KB

722 INCIDENCE AND DETERMINANTS OF SPONTA

722 INCIDENCE AND DETERMINANTS OF SPONTANEOUS HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE: A COMMUNITY-BASED LONG-TERM FOLLOW-UP STUDY

✍ J. Liu; H.-I. Yang; M.-H. Lee; S.-N. Lu; C.-L. Jen; L.-Y. Wang; S.-L. You; U.H. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 92 KB

[474] FACTORS ASSOCIATED WITH SEROCLEARA

[474] FACTORS ASSOCIATED WITH SEROCLEARANCE OF HEPATITIS B e ANTIGEN: A LONG-TERM FOLLOW-UP STUDY

✍ C.A. Chen; P.J. Chen; H.I. Yang; U.H. Iloeje; J. Su; C.L. Jen; S.H. Yeh; S.N. Lu 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Long-term follow-up of peginterferon and

Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B

✍ Henry Lik-Yuen Chan; Alex Yui Hui; Vincent Wai-Sun Wong; Angel Mei-Ling Chim; Ma 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

We have previously demonstrated that combination peginterferon and lamivudine treatment has superior antiviral efficacy to lamivudine monotherapy in chronic hepatitis B. In this study, we investigated the long-term posttreatment virological response to this combination treatment. Sustained virologic

Excess mortality in patients with advanc

Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon

✍ Adrian M. Di Bisceglie; Anne M. Stoddard; Jules L. Dienstag; Mitchell L. Shiffma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

for the HALT-C Trial Group Chronic hepatitis C virus infection can cause chronic liver disease, cirrhosis and liver cancer. The Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial was a prospective, randomized controlled study of long-term, low-dose peginterferon therapy in pa

Sustained hepatitis C virus clearance an

Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up

✍ Yu, Ming-Lung; Lee, Chuan-Mo; Chen, Chi-Ling; Chuang, Wan-Long; Lu, Sheng-Nan; L 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 526 KB